UNH

$407.150.67%2.705

Unitedhealth Group Inc (UNH)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$404.44

Offen:

$396.60

24-Stunden-Volumen:

4,230,906

Relatives Volumen:

0.97

Marktkapitalisierung:

$365.45B

Einnahmen:

$450.13B

Nettoeinkommen (Verlust:

$14.91B

KGV:

26.18

EPS:

$15.55

Netto-Cashflow:

$23.62B

1W Leistung:

+0.01%

1M Leistung:

+9.48%

6M Leistung:

+9.82%

1Y Leistung:

+23.07%

1-Tages-Spanne:

$392.50$408.17

1-Wochen-Bereich:

$394.11$416.11

52-Wochen-Spanne:

$255.97$461.62

Unitedhealth Group Inc Aktie (UNH) Unternehmensprofil

Firmenname

Unitedhealth Group Inc

Sektor

Healthcare

Branche

Healthcare Plans

Telefon

1-800-328-5979

Adresse

1 HEALTH DRIVE, EDEN PRAIRIE, USA

Mitarbeiter

390,000

@unitedhealthgrp

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

UNH-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Unitedhealth Group Inc Aktie (UNH) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-08-27	Herabstufung	Erste Group	Buy → Hold
2026-07-16	Hochstufung	Robert W. Baird	Underperform → Neutral
2026-06-17	Bestätigt	Leerink Partners	Outperform
2026-06-04	Hochstufung	BofA Securities	Neutral → Buy
2026-04-27	Hochstufung	Erste Group	Hold → Buy
2026-04-22	Hochstufung	Argus	Hold → Buy
2026-04-07	Hochstufung	HSBC Securities	Reduce → Hold
2026-04-01	Hochstufung	Raymond James	Mkt Perform → Outperform
2025-10-29	Herabstufung	Deutsche Bank	Buy → Hold
2025-10-14	Eingeleitet	Goldman	Buy
2025-07-31	Herabstufung	Robert W. Baird	Neutral → Underperform
2025-07-30	Bestätigt	Oppenheimer	Outperform
2025-06-11	Herabstufung	Robert W. Baird	Outperform → Neutral
2025-05-21	Herabstufung	HSBC Securities	Hold → Reduce
2025-05-19	Herabstufung	TD Cowen	Buy → Hold
2025-05-14	Herabstufung	BofA Securities	Buy → Neutral
2025-05-14	Herabstufung	Raymond James	Strong Buy → Mkt Perform
2025-04-22	Herabstufung	HSBC Securities	Buy → Hold
2025-04-21	Herabstufung	Argus	Buy → Hold
2025-01-10	Hochstufung	HSBC Securities	Hold → Buy
2025-01-06	Bestätigt	Truist	Buy
2024-10-17	Herabstufung	HSBC Securities	Buy → Hold
2024-10-11	Eingeleitet	KeyBanc Capital Markets	Overweight
2024-07-17	Hochstufung	Jefferies	Hold → Buy
2024-07-17	Bestätigt	RBC Capital Mkts	Outperform
2024-06-05	Hochstufung	HSBC Securities	Hold → Buy
2024-05-30	Eingeleitet	Robert W. Baird	Outperform
2024-04-04	Hochstufung	HSBC Securities	Reduce → Hold
2024-03-06	Eingeleitet	Barclays	Overweight
2023-12-18	Herabstufung	HSBC Securities	Hold → Reduce
2023-10-16	Hochstufung	UBS	Neutral → Buy
2023-09-06	Eingeleitet	HSBC Securities	Hold
2023-07-19	Bestätigt	UBS	Neutral
2023-07-18	Hochstufung	Bernstein	Mkt Perform → Outperform
2023-07-17	Bestätigt	JP Morgan	Overweight
2023-07-17	Bestätigt	RBC Capital Mkts	Outperform
2023-07-17	Bestätigt	TD Cowen	Outperform
2023-05-26	Eingeleitet	Piper Sandler	Overweight
2023-04-21	Eingeleitet	Cantor Fitzgerald	Overweight
2023-04-05	Hochstufung	Raymond James	Outperform → Strong Buy
2022-11-23	Resumed	Morgan Stanley	Overweight
2022-11-21	Herabstufung	Raymond James	Strong Buy → Outperform
2022-06-17	Eingeleitet	Loop Capital	Buy
2022-05-27	Herabstufung	Bernstein	Outperform → Mkt Perform
2021-12-14	Eingeleitet	Goldman	Buy
2021-09-27	Eingeleitet	SVB Leerink	Outperform
2021-09-10	Eingeleitet	Cowen	Outperform
2021-07-09	Eingeleitet	Seaport Global Securities	Buy
2021-06-01	Bestätigt	BofA Securities	Buy
2021-05-19	Eingeleitet	Wells Fargo	Overweight
2021-04-21	Hochstufung	Argus	Hold → Buy
2020-10-19	Herabstufung	Argus	Buy → Hold
2020-07-01	Resumed	SVB Leerink	Outperform
2020-06-05	Eingeleitet	Goldman	Buy
2020-03-20	Hochstufung	Deutsche Bank	Hold → Buy
2019-10-18	Eingeleitet	Mizuho	Buy
2019-10-10	Herabstufung	Jefferies	Buy → Hold
2019-09-30	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2019-09-12	Eingeleitet	Deutsche Bank	Hold
2019-05-10	Hochstufung	Citigroup	Neutral → Buy
2019-04-23	Eingeleitet	UBS	Neutral
2019-04-17	Bestätigt	BofA/Merrill	Buy
2019-01-14	Eingeleitet	Stephens	Overweight
2018-09-10	Herabstufung	Citigroup	Buy → Neutral
2018-06-11	Eingeleitet	SunTrust	Buy
2018-03-08	Eingeleitet	Barclays	Overweight
2018-01-17	Bestätigt	Citigroup	Buy
2018-01-12	Bestätigt	Evercore ISI	Outperform
2018-01-03	Eingeleitet	Goldman	Buy
2017-07-19	Bestätigt	Mizuho	Buy
2017-06-07	Eingeleitet	Morgan Stanley	Overweight

Finanzdaten der Unitedhealth Group Inc-Aktie (UNH)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	447,567.00	400,278.00	371,622.00	324,162.00	287,597.00
Cost of revenue USD (M)	50,655.00	46,694.00	38,770.00	33,703.00	31,034.00
Gross profit USD (M)	-	-	332,852.00	290,459.00	256,563.00
Operating expenses USD (M)	428,603.00	367,991.00	300,494.00	262,024.00	232,593.00
Operating income USD (M)	18,964.00	32,287.00	32,358.00	28,435.00	23,970.00
Income before tax USD (M)	14,697.00	20,071.00	29,112.00	26,343.00	22,310.00
Income tax expense USD (M)	1,890.00	4,829.00	5,968.00	5,704.00	4,578.00
Net income USD (M)	12,807.00	15,242.00	23,144.00	20,639.00	17,732.00
Basic EPS USD/shares	13.28	15.64	24.12	21.47	18.33
Diluted EPS USD/shares	13.23	15.51	23.86	21.18	18.08
Basic weighted shares shares (M)	908.00	921.00	928.00	937.00	943.00
Diluted weighted shares shares (M)	911.00	929.00	938.00	950.00	956.00
Selling, general and administrative USD (M)	59,592.00	53,013.00	54,628.00	47,782.00	42,579.00

Unitedhealth Group Inc-Aktie (UNH) Insiderhandel

Conway Patrick HughAug 21 '26
Chief Executive Officer, Optum
Transaktion
Sale
Kosten
$390.00
#Aktien
1,169
Wert ($)
455,910
#Aktien Gesamt
15,328
Conway Patrick HughAug 21 '26
Officer
Transaktion
Proposed Sale
Kosten
$390.00
#Aktien
1,169
Wert ($)
455,910
#Aktien Gesamt
0
Conway Patrick HughAug 05 '26
Chief Executive Officer, Optum
Transaktion
Sale
Kosten
$410.00
#Aktien
500
Wert ($)
205,000
#Aktien Gesamt
16,497
Conway Patrick HughAug 05 '26
Officer
Transaktion
Proposed Sale
Kosten
$410.00
#Aktien
500
Wert ($)
205,000
#Aktien Gesamt
0
Conway Patrick HughApr 23 '26
Chief Executive Officer, Optum
Transaktion
Sale
Kosten
$355.00
#Aktien
800
Wert ($)
284,000
#Aktien Gesamt
17,805
Conway Patrick HughApr 23 '26
Officer
Transaktion
Proposed Sale
Kosten
$355.00
#Aktien
800
Wert ($)
284,000
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Conway Patrick Hugh	Chief Executive Officer, Optum	Aug 21 '26	Sale	$390.00	1,169	455,910	15,328
Conway Patrick Hugh	Officer	Aug 21 '26	Proposed Sale	$390.00	1,169	455,910	0
Conway Patrick Hugh	Chief Executive Officer, Optum	Aug 05 '26	Sale	$410.00	500	205,000	16,497
Conway Patrick Hugh	Officer	Aug 05 '26	Proposed Sale	$410.00	500	205,000	0
Conway Patrick Hugh	Chief Executive Officer, Optum	Apr 23 '26	Sale	$355.00	800	284,000	17,805
Conway Patrick Hugh	Officer	Apr 23 '26	Proposed Sale	$355.00	800	284,000	0

Unitedhealth Group Inc Aktie (UNH) Neueste Nachrichten

05:20 AM

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)? - Zacks Investment Research

05:20 AM

Nov 03, 2026

Top Wide-Moat Stocks to Buy for Steady Long-Term Returns - Zacks Investment Research

Nov 03, 2026

Nov 02, 2026

Will UNH's Optum Insight Spending Translate Into Profit Growth? - Zacks Investment Research

Nov 02, 2026

Oct 29, 2026

THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised - Zacks Investment Research

Oct 29, 2026

Oct 26, 2026

CVS Health Q3 Earnings Preview: How to Approach the Stock? - Zacks Investment Research

Oct 26, 2026

Oct 24, 2026

Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy? - The Motley Fool

Oct 24, 2026

Oct 20, 2026

The Zacks Analyst Blog Highlights UnitedHealth, ServiceNow, 3M and Coffee - Zacks Investment Research

Oct 20, 2026

Oct 19, 2026

Top Research Reports for UnitedHealth, ServiceNow & 3M - Zacks Investment Research

Oct 19, 2026

UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy? - Zacks Investment Research

Oct 16, 2026

Oct 15, 2026

3 Companies Raising Guidance This Earnings Season - Zacks Investment Research

Oct 15, 2026

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge - Zacks Investment Research

Oct 15, 2026

Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? - Zacks Investment Research

Oct 15, 2026

Oct 14, 2026

UNH Stock Jumps As Earnings Beat And Guidance Hike Fuel Momentum - Timothy Sykes

Oct 14, 2026

Centene's Gold Card Push Could Ease Costs - But Will Savings Follow? - Zacks Investment Research

Oct 14, 2026

UNH Q3 Earnings Call Highlights 2027 Growth and Margin Recovery - Zacks Investment Research

Oct 14, 2026

UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy? - Zacks Investment Research

Oct 14, 2026

Oct 13, 2026

UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings? - Zacks Investment Research

Oct 13, 2026

Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve - Zacks Investment Research

Oct 13, 2026

Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich? - Zacks Investment Research

Oct 13, 2026

Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going? - Zacks Investment Research

Oct 13, 2026

Stock Market Midday, Oct. 13: Bank Earnings and Chip Pressure Drive Mixed Trading - The Motley Fool

Oct 13, 2026

UNH Tops Q3 Earnings on Lower Medical Costs, Raises '26 Outlook - Zacks Investment Research

Oct 13, 2026

Revenue slips to $112.7B as UnitedHealth (UNH) raises its 2026 earnings outlook. - Stock Titan

Oct 13, 2026

UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates - Zacks Investment Research

Oct 13, 2026

Oct 12, 2026

Middle East Tensions Rattle Markets - Zacks Investment Research

Oct 12, 2026

Big Week of Data: Inflation & Q3 Earnings - Zacks Investment Research

Oct 12, 2026

Oct 09, 2026

Estimates Keep Rising as Q3 Earnings Season Takes Center Stage - Zacks Investment Research

Oct 09, 2026

UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know - Zacks Investment Research

Oct 09, 2026

UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Zacks Investment Research

Oct 09, 2026

Oct 08, 2026

UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research

Oct 08, 2026

CVS Health Trades at a Discount to Industry: How to Play the Stock? - Zacks Investment Research

Oct 08, 2026

UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? - Zacks Investment Research

Oct 08, 2026

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research

Oct 08, 2026

Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now? - Zacks Investment Research

Oct 08, 2026

Oct 07, 2026

Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research

Oct 06, 2026

Ensign Builds More Scale as Financial Flexibility Remains Strong - Zacks Investment Research

Oct 06, 2026

Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Zacks Investment Research

Oct 06, 2026

Here's Why UnitedHealth Group (UNH) is a Strong Value Stock - Zacks Investment Research

Oct 06, 2026

Oct 03, 2026

UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching. - The Motley Fool

Oct 03, 2026

UnitedHealth Group Incorporated (UNH) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 03, 2026

Oct 02, 2026

UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing - Zacks Investment Research

Oct 02, 2026

Sep 30, 2026

Warren Buffett's Record: $1,000 Became About $61 Million. Can Greg Abel Keep Compounding It? - The Motley Fool

Sep 30, 2026

Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies - GlobeNewswire Inc.

Sep 30, 2026

Sep 29, 2026

(UNH) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Sep 29, 2026

Sep 24, 2026

Reuters Momentum AI Austin Day 1: A New Way to Measure Whether AI Is Actually Paying Off - GlobeNewswire Inc.

Sep 24, 2026

Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region - GlobeNewswire Inc.

Sep 24, 2026

Ähnlich wie UNH

Unitedhealth Group Inc (UNH)

Unitedhealth Group Inc Aktie (UNH) Unternehmensprofil

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Unitedhealth Group Inc Aktie (UNH) Hochstufungen & Herabstufungen

Finanzdaten der Unitedhealth Group Inc-Aktie (UNH)

Unitedhealth Group Inc-Aktie (UNH) Insiderhandel

Unitedhealth Group Inc Aktie (UNH) Neueste Nachrichten

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)? - Zacks Investment Research

Top Wide-Moat Stocks to Buy for Steady Long-Term Returns - Zacks Investment Research

Will UNH's Optum Insight Spending Translate Into Profit Growth? - Zacks Investment Research

THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised - Zacks Investment Research

CVS Health Q3 Earnings Preview: How to Approach the Stock? - Zacks Investment Research

Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy? - The Motley Fool

The Zacks Analyst Blog Highlights UnitedHealth, ServiceNow, 3M and Coffee - Zacks Investment Research

Top Research Reports for UnitedHealth, ServiceNow & 3M - Zacks Investment Research

Understanding the Setup: (UNH) and Scalable Risk - Stock Traders Daily

Crypto Vane(@Square-Creator-1befb85744d6)'s insights - Binance

UnitedHealth: 3 Key Takeaways for Long-Term Investors - The Motley Fool

UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy? - Zacks Investment Research

3 Companies Raising Guidance This Earnings Season - Zacks Investment Research

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge - Zacks Investment Research

Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? - Zacks Investment Research

UNH Stock Jumps As Earnings Beat And Guidance Hike Fuel Momentum - Timothy Sykes

Centene's Gold Card Push Could Ease Costs - But Will Savings Follow? - Zacks Investment Research

UNH Q3 Earnings Call Highlights 2027 Growth and Margin Recovery - Zacks Investment Research

UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy? - Zacks Investment Research

UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings? - Zacks Investment Research

Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve - Zacks Investment Research

Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich? - Zacks Investment Research

Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going? - Zacks Investment Research

Stock Market Midday, Oct. 13: Bank Earnings and Chip Pressure Drive Mixed Trading - The Motley Fool

UNH Tops Q3 Earnings on Lower Medical Costs, Raises '26 Outlook - Zacks Investment Research

Revenue slips to $112.7B as UnitedHealth (UNH) raises its 2026 earnings outlook. - Stock Titan

UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates - Zacks Investment Research

Middle East Tensions Rattle Markets - Zacks Investment Research

Big Week of Data: Inflation & Q3 Earnings - Zacks Investment Research

Estimates Keep Rising as Q3 Earnings Season Takes Center Stage - Zacks Investment Research

UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know - Zacks Investment Research

UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Zacks Investment Research

UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research

CVS Health Trades at a Discount to Industry: How to Play the Stock? - Zacks Investment Research

UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? - Zacks Investment Research

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research

Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now? - Zacks Investment Research

Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research

UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research

Ensign Builds More Scale as Financial Flexibility Remains Strong - Zacks Investment Research

Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Zacks Investment Research

Here's Why UnitedHealth Group (UNH) is a Strong Value Stock - Zacks Investment Research

UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching. - The Motley Fool

UnitedHealth Group Incorporated (UNH) Stock Price, News, Quote & History - Yahoo! Finance Canada

UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing - Zacks Investment Research

Warren Buffett's Record: $1,000 Became About $61 Million. Can Greg Abel Keep Compounding It? - The Motley Fool

Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies - GlobeNewswire Inc.

(UNH) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Reuters Momentum AI Austin Day 1: A New Way to Measure Whether AI Is Actually Paying Off - GlobeNewswire Inc.

Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region - GlobeNewswire Inc.

Ähnlich wie UNH